LGALS4

Galectin-4 · P56470 · LGALS4 on Sugi Atlas →

19,335 patent compounds predicted against LGALS4, 14,094 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL1521368 SCHEMBL1521368 0.52 4/20
SCHEMBL1682156 SCHEMBL1682156 0.52 4/20
SCHEMBL1682180 SCHEMBL1682180 0.52 4/20
SCHEMBL411273 SCHEMBL411273 0.77 3/20
SCHEMBL411274 SCHEMBL411274 0.77 3/20
SCHEMBL411624 SCHEMBL411624 0.77 3/20
SCHEMBL411625 SCHEMBL411625 0.77 3/20
SCHEMBL736151 SCHEMBL736151 0.77 3/20
SCHEMBL416471 SCHEMBL416471 0.72 3/20
SCHEMBL2190560 SCHEMBL2190560 0.68 3/20
SCHEMBL754690 SCHEMBL754690 0.67 3/20
SCHEMBL754691 SCHEMBL754691 0.67 3/20
SCHEMBL769002 SCHEMBL769002 0.62 3/20
SCHEMBL887972 SCHEMBL887972 0.62 3/20
SCHEMBL887984 SCHEMBL887984 0.62 3/20
SCHEMBL889532 SCHEMBL889532 0.62 3/20
SCHEMBL889573 SCHEMBL889573 0.62 3/20
SCHEMBL890313 SCHEMBL890313 0.62 3/20
SCHEMBL411272 SCHEMBL411272 0.61 3/20
SCHEMBL411623 SCHEMBL411623 0.61 3/20

Clinical trials — most relevant to LGALS4 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Study of Sacubitril/ValsarTan on MyocardIal OxygenatioN and Fibrosis in Heart Failure With Preserved Ejection Fraction PHASE3WITHDRAWN
A Phase 2 Extension of Study GCS-100-CS-4003 PHASE2WITHDRAWN
A Phase 2b Study of GCS-100 in Patients With Chronic Kidney Disease Caused by Diabetes PHASE2UNKNOWN
A Phase 2a Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease PHASE2COMPLETED
Vitamin D Deficiency Treatment Outcomes After Non-ST-Segment Elevation Myocardial Infarction PHASE2UNKNOWN
Effect of Modified Citrus Pectin on PSA Kinetics in Biochemical Relapsed PC With Serial Increases in PSA PHASE2COMPLETED
A Phase 2 Extension Study of Study GCS-100-CS-4002 PHASE2COMPLETED
GR-MD-02 Plus Pembrolizumab in Melanoma, Non-small Cell Lung Cancer, and Squamous Cell Head and Neck Cancer Patients PHASE1COMPLETED
The Diagnostic Value of Serum Oncostatin M and Galactin 3 as Biomarkers in Diagnosis of Ulcerative Colitis Disease nanNOT_YET_RECRUITING
A Wearable Device and AI-Supported Diet and Exercise Intervention nanRECRUITING
Urinary G3BP as a Novel Biomarker in Lupus Nephritis nanNOT_YET_RECRUITING
A Serum Galectin-3 Levels in Placenta Accreta Spectrum Pregnancies nanCOMPLETED
The Role of Galectins in the Non-invasive Diagnosis of Endometriosis nanUNKNOWN
Galectin and Respiratory Weaning nanUNKNOWN
Testicular Proteins for Sperm Retrieval Prediction Protein1, Testis-Expressed Gene 101, and Lectin Galactoside-binding Protein in Predicting Surgical Sperm Retrieval in Men With Non-Obstructive Azoospermia nanUNKNOWN
Galectin-3 Binding Protein in Cardiovascular Disease and Chronic Heart Failure nanCOMPLETED
Effect of Low-Glycemic Index Mediterranean Diet on AGEs nanCOMPLETED
Galectin-3 for Thromboembolic Formation in Patients With Atrial Fibrillation CHA₂DS₂-VASc Scoring nanUNKNOWN
Galectin-3 in Septic and Non-septic Acute Kidney Injury nanUNKNOWN
Galectin 3 Dosage in Diagnosis of Nodular and Multinodular Goiter nanCOMPLETED
Galectin-3 as a Biomarker in Patients With Chagas Disease nanCOMPLETED
Evaluation of Serum Galectin-9 Level in Systemic Lupus Erythematosus Patients and it's Association With Disease Activity and Organ Damage nanUNKNOWN
Blood Collection From Heart Failure Patients to Evaluate for Galectin-3 Measurement Differences Using Various Collection Tubes nanCOMPLETED
Serum Galectin-3 as a Marker of Human Papillomavirus Infection nanCOMPLETED
Evaluation of Galectin-3 in Serum and Saliva of Pemphigus Patients nanUNKNOWN
Biomarkers for Risk Stratification After STEMI nanUNKNOWN
Galectin-3 in Patients With Endometriosis nanUNKNOWN
Fontan Imaging Biomarkers (FIB) Study nanCOMPLETED
Glycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal Lymph Nodes nanCOMPLETED
Correlational Study on the Biomarkers Application to the Prediction and Diagnosis of Cardiovascular Diseases nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a LGALS4 binder may also engage these)

ProteinNameSimilarity
Q29058 0.999 Q29058 →
P38552 0.998 P38552 →
O54891 0.997 O54891 →
Q8K419 0.993 Q8K419 →
Q3T0D6 0.992 Q3T0D6 →
P97840 0.986 P97840 →
O08573 0.984 O08573 →
Q6DKI2 0.981 Q6DKI2 →
LGALS9 Galectin-9 0.978 landscape →
Q3MHZ8 0.978 Q3MHZ8 →
Q3B8N2 0.978 Q3B8N2 →
P07583 0.974 P07583 →
P47967 0.972 P47967 →
P47845 0.970 P47845 →
Q62665 0.970 Q62665 →
LGALS3 Galectin-3 0.967 landscape →
P97590 0.967 P97590 →
Q9JL15 0.967 Q9JL15 →
P47953 0.966 P47953 →
LGALS8 Galectin-8 0.965 landscape →
O44126 0.965 O44126 →
P11762 0.964 P11762 →
P36573 0.963 P36573 →
Q05315 0.961 Q05315 →
Q09581 0.959 Q09581 →
Q5R7M1 0.959 Q5R7M1 →
P16110 0.959 P16110 →
Q9Z144 0.959 Q9Z144 →
C0HJR3 0.958 C0HJR3 →
P08699 0.955 P08699 →